Vitamin D and falls - the dosage conundrum

Area of Science:

• Gerontology
• Nutritional Science
• Public Health

Background:

• Falls pose a significant health risk for older adults, with limited long-term practicality of current interventions like physical therapy.
• Vitamin D supplementation has been investigated for fall prevention, but daily oral dose studies yielded inconsistent results.
• Recent studies on high-dose vitamin D boluses have shown unexpected adverse effects.

Purpose of the Study:

• To investigate the effects of different vitamin D dosing regimens on fall and fracture rates in the elderly.
• To determine safe upper limits for vitamin D supplementation and resulting serum levels in older adults.

Main Methods:

• Analysis of studies examining annual or monthly high-dose vitamin D (bolus) administration.
• Correlation of serum 25-hydroxyvitamin D levels with fall and fracture incidence.
• Review of adverse events associated with vitamin D supplementation.

Main Results:

• High-dose vitamin D boluses (annual or monthly) were associated with a significant increase in falls and fractures.
• Increased adverse events correlated with serum 25-hydroxyvitamin D levels exceeding 40-45 ng/ml.
• Existing daily oral dose studies showed inconsistent outcomes.

Conclusions:

• High-dose vitamin D, particularly bolus administration, may increase fall and fracture risks in the elderly.
• Recommended maximum daily vitamin D intake should not exceed 3,000 IU.
• Serum 25-hydroxyvitamin D levels in the elderly should be maintained below 40-45 ng/ml pending further safety data.